Key facts
- This page summarizes Eric A. Rose MD's Form 4 filing for Orchestra BioMed Holdings, Inc. (OBIO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Jun 2024, 17:56.
Eric A. Rose MD - 20 Jun 2024 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)
- Reporting relationship
- Director
- Issuer ticker
- OBIO
- Reported as of
- 20 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Jun 2024, 17:56:05 UTC
- Prior SEC filing
- 24 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Silas Newcomb, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Eric A. Rose MD filed Form 4 for Orchestra BioMed Holdings, Inc. (OBIO) on 21 Jun 2024.
Change
- Previous filing in this sequence was filed on 24 Jul 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OBIO
transaction
Common Stock, par value $0.0001 per share ("Common Stock")
Award
- Transaction value
- $0
- Shares
- +5,376
- Change %
- +248%
- Price
- $0.000000
- Shares after
- 7,544
- Date
- 20 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OBIO
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +17,068
- Change %
- Price
- $0.000000
- Shares after
- 17,068
- Date
- 20 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,068
- Exercise price
- $7.44
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 20, 2025.